I am looking for a pathology image analysis software that uses AI to detect cancer cells.

Several prominent software platforms use artificial intelligence (AI) and machine learning to analyze whole-slide pathology images and detect cancer cells or suspicious regions . These tools typically act as a digital "second set of eyes" to highlight areas of interest, quantify tumor metrics, and streamline diagnostic workflows.

• Paige - Offers clinically validated AI suites (such as Paige Prostate, Breast, and GI Suites) designed to assist pathologists in identifying and classifying malignant conditions. Their advanced tool, Paige PanCancer Detect, holds FDA Breakthrough Device designation for identifying common and rare cancers across multiple tissue types.
• Aiforia - Provides cloud-based AI software and a broad portfolio of quantitative AI models specifically trained for detecting various cancers (including breast, lung, prostate, and colorectal cancer) and analyzing metastases in lymph nodes. It allows users to run automated, high-accuracy analysis on digital tissue samples.
• PathAI - Develops AI-powered pathology products aimed at improving diagnostic accuracy and helping develop companion diagnostics. Their technology assists in identifying disease features, quantifying cellular elements, and supporting pathologists with complex decisions in areas like oncology and metabolic disease.
• Nuclei.io - A human-in-the-loop digital pathology platform that allows pathologists to adapt and utilize customizable AI models to highlight regions containing malignant-looking cells or specific cell types directly within gigabyte-scale tissue images.

If you can share which specific cancer type or tissue you are targeting (e.g., prostate, breast, lung) and whether you need this for clinical diagnostic use or academic research , I can help narrow down the most suitable platform.

If you are looking for AI-powered pathology image analysis software to detect cancer cells, you are generally looking for a computational pathology / digital pathology AI platform. These systems analyze digitized whole-slide images (WSI) from pathology scanners and can help detect tumor regions, classify cells, quantify biomarkers, or assist pathologists in diagnosis. They are usually decision-support tools, not replacements for a pathologist.

Here are some established options:

If you are choosing software, consider:

• Cancer type: prostate, breast, lung, colorectal, melanoma, etc. Many AI models are cancer-specific.
• Use case: - Screening/detection of suspicious cancer areas
• Tumor segmentation
• Cell counting
• Biomarker scoring (HER2, PD-L1, Ki-67, ER/PR)
• Research biomarker discovery
• Regulatory status: Some tools are FDA-authorized or CE-marked for specific uses; many others are research-use-only.
• Compatibility: Check support for your scanner (e.g., Leica, Philips, Hamamatsu, Roche/Ventana) and image formats.
• Deployment: Cloud-based vs. installed locally inside a hospital/research network.

If you tell me your situation (for example: hospital pathology department, university research lab, biotech/pharma, or personal learning) and the cancer type you need to detect, I can narrow this to the most suitable options.

Several advanced software platforms use artificial intelligence and deep learning to analyze whole-slide pathology images, detect cancer cells, and quantify biomarkers . Depending on whether you need a tool for clinical diagnostics (regulatory-cleared) or research use only (RUO/trainable), here are the leading options:

1. Clinical & Diagnostic AI Solutions (Regulatory Cleared / CE-IVD)

• Paige (Paige Prostate / Paige Breast)
  • Overview: One of the pioneers in computational pathology. Paige Prostate was the first FDA-cleared AI product for pathology, designed to identify prostate cancer in biopsy slides. They also offer broad applications for breast and gastrointestinal tract pathologies, alongside their developmental PanCancer Detect tool.
  • Best for: Clinical diagnostic decision support in professional pathology labs. Explore their suite on the Paige.ai platform.
• Aiforia
  • Overview: Provides a powerful cloud-based platform with deep learning models specifically pre-trained for various oncology applications. Their portfolio includes targeted suites for breast cancer, lung cancer, prostate cancer, colon suites, and lymph node metastasis detection.
  • Best for: Automated quantitative pathology workflows and dense tissue analysis. Learn more at Aiforia.
• Mindpeak
  • Overview: A German-based AI software provider focusing heavily on assisting pathologists with routine cancer immunohistochemistry (IHC) evaluations, such as breast cancer biomarker quantification (Ki67, ER, PR).
  • Best for: Fast, standardized biomarker scoring in diagnostic pathology.

2. Research, Discovery & Trainable AI Platforms (RUO)

• HALO AI by Indica Labs
  • Overview: Widely considered an industry standard for digital pathology research. HALO AI allows users to use deep learning to train custom classifiers and object phenotype models (such as their pre-built non-small cell lung cancer or breast cancer cell phenotyper apps) to detect, segment, and count specific cancer cells versus stroma or immune cells.
  • Best for: Academic and pharmaceutical research where custom, trainable machine learning models are required. Check out the specifications at Indica Labs HALO AI.
• Visiopharm
  • Overview: Offers application suites powered by AI for precision pathology. It features CE-IVD certified clinical algorithms as well as research tools for automated scoring of breast panels, lung cancer, and inflammatory markers with high precision.

To help narrow down the right platform for you, could you tell me:

• Are you looking for clinical diagnostics (patient care/FDA-cleared) or research use only (RUO)?
• Which specific tissue types or cancers (e.g., prostate, breast, lung) are you focusing on?

Yes. There are several AI-powered digital pathology platforms that can analyze whole-slide images (WSIs) and flag or quantify cancerous tissue/cells. The best choice depends heavily on the cancer type, whether this is for clinical diagnosis vs. research, and what scanner/image format you use.

Strong options to consider

• paige.ai — Probably the first platform I would evaluate for clinical cancer detection. It offers AI applications for prostate, breast, GI, colon, and broader cancer detection. Its Paige Prostate Detect was the first AI pathology software authorized by the FDA to aid in primary diagnosis of prostate cancer.
• aiforia.com — Offers AI-based image analysis for prostate, breast, colon, gastric, lung and lymph-node pathology. It is particularly interesting if you need quantitative cell/tissue analysis and automated scoring rather than simply flagging suspicious regions.
• pathai.com — Its AISight Dx is an FDA-cleared digital pathology image-management platform for primary diagnosis, with an ecosystem of AI algorithms from PathAI and partners. This can be attractive if you want a broader digital-pathology infrastructure rather than a single cancer detector.
• Mindpeak — Particularly interesting if your goal is individual tumor-cell detection and quantification on IHC slides. Its algorithms can segment tumor tissue and detect/classify/quantify tumor cells for biomarkers such as HER2, ER/PR, Ki-67 and PD-L1.

If your goal is specifically "detect cancer cells"

I'd narrow the choice based on the application:

Paige's current portfolio, for example, includes applications that highlight suspicious cancer foci, detect metastases, identify mitotic figures, and quantify tumor burden—not merely classify an entire slide as cancer/no cancer.

If you tell me (1) the cancer/tissue type, (2) whether you're a research lab or clinical diagnostic lab, and (3) whether you have H&E, IHC, or both, I can narrow this to 3–5 specific products, including approximate pricing/licensing, supported scanners, FDA/CE status, and whether they can actually detect individual cancer cells.

Yes. There are several AI-powered digital pathology platforms that analyze whole-slide images (WSIs) and identify cancer cells or suspicious tumor regions. The best choice depends heavily on whether you need clinical diagnosis, research, or custom AI model development.

Strong options to investigate

⭐ If your primary goal is detecting cancer cells

1. Paige — probably the first one I'd investigate.

Paige's Paige Prostate Detect analyzes H&E-stained prostate biopsy whole-slide images and identifies areas suspicious for prostate cancer. Paige says it was the first AI pathology software to receive FDA approval to aid in the primary diagnosis of prostate cancer.

The FDA's current database also lists Paige under the regulatory category for software algorithms that assist with evaluating scanned pathology whole-slide images for clinically relevant areas.

2. Ibex Medical Analytics — another strong clinical option.

Ibex's platform is designed to detect and grade cancer across multiple tissues, including breast, prostate and gastric cancer, and supports more than 100 clinically relevant pathology features. ibex-ai.com A recent 2026 review identifies Paige Prostate Detect and Ibex Prostate Detect as the two FDA-cleared AI tools for prostate biopsy interpretation.

3. Aiforia — particularly interesting if you want flexibility.

Aiforia has clinical AI suites for breast, lung, prostate, colorectal, gastric cancer and lymph-node metastases. It also provides Aiforia Create, which allows researchers to develop their own deep-learning models by annotating pathology images—useful if you want the AI to recognize a particular cancer or cellular feature that isn't covered by an off-the-shelf model.

4. PathAI — excellent for research/biomarker analysis.

PathAI's AISight platform provides algorithms for tumor detection, tumor-cellularity quantification and biomarkers such as PD-L1 and HER2. Its platform also integrates AI products from companies including Paige, Deep Bio, DoMore Diagnostics and Visiopharm.

One important distinction

If by "detect cancer cells" you mean:

Upload a pathology slide → AI automatically finds individual malignant cells/tumor regions → highlights them → gives me a count/percentage

then Aiforia, PathAI, and HALO are particularly worth examining for research/image-analysis applications.

If you mean:

A pathologist is diagnosing a patient's biopsy and wants FDA-cleared AI assistance

then Paige and Ibex deserve particular attention. Regulatory status varies by specific software, cancer type, country, and intended use, so you shouldn't assume that an AI model marketed for research is authorized for clinical diagnosis. Aiforia, for example, explicitly distinguishes its CE-IVD clinical models from research-only use in other markets.

If you tell me what type of cancer/tissue you're working with (e.g., breast, prostate, colon, lung), whether this is for research or clinical diagnosis, and what slide format/scanner you have (SVS, TIFF, NDPI, etc.), I can narrow this down to 3–5 specific programs and compare their price, AI capabilities, hardware requirements, FDA status, and whether you can upload your own pathology images.

Several prominent software platforms utilize artificial intelligence and deep learning for whole-slide image (WSI) analysis and cancer cell detection . Depending on whether you need a clinical diagnostic assistant or a research-only toolkit, options include:

• Paige AI : Known for pioneering regulatory-cleared pathology AI, Paige offers applications targeting prostate, breast, and gastrointestinal cancers. Their broader toolkit, such as Paige PanCancer Detect, is designed to identify suspicious foci across multiple tissue types.
• Aiforia : Provides a cloud-based platform with a robust portfolio of quantitative AI models and suites for breast, lung, prostate, colon, and gastric cancers. Many of their clinical solutions carry CE-IVD markings.
• PathAI : Features AISight , a cloud-native enterprise image management system integrated with advanced AI applications designed to assist laboratories with case workflows, biomarker quantification, and accurate histopathology reviews.
• Visiopharm : Offers specialized AI algorithms and "Q-Apps" for precision pathology, automating tumor detection, nuclear morphology analysis, and immune cell infiltration scoring in brightfield and fluorescent whole-slide images.
• Mindpeak : Develops fast AI solutions focused on augmenting pathologist workflows, offering automated scoring and panels for breast cancer markers (such as Ki-67, ER, PR, and HER2).

To help narrow down the best platform, could you let me know:

• Are you looking for a solution for clinical diagnostic use or academic/pharma research?
• Which specific cancer types or tissue samples are you prioritizing?

Several prominent software platforms utilize artificial intelligence (AI) and machine learning for whole-slide image (WSI) analysis, cancer cell detection, and biomarker quantification.

• Paige (via Tempus AI) - Specializes in clinical-grade AI applications for pathology. Its suite includes FDA-cleared tools for prostate and breast cancer detection, as well as the broad multi-tissue screening tool Paige PanCancer Detect . You can explore their offerings on Paige.
• PathAI (AISight) - Offers a vendor-agnostic, cloud-native enterprise workflow and image management platform integrated with advanced AI tools for pathology diagnostics, cell counting, and tumor segmentation. More information is available on PathAI.
• Aiforia - Provides a comprehensive platform with deep-learning AI models and suites tailored for specific oncology areas, including breast, prostate, lung, and colorectal cancer quantification. Learn more at Aiforia.
• Artera - Focuses on multimodal AI (MMAI) for prognostic cancer risk stratification, featuring FDA-cleared assays for both prostate and early-stage breast cancer management. Details can be found at Artera.
• Proscia (Concentriq) - Delivers an enterprise digital pathology platform widely used in laboratories and pharmaceutical R&D to host and scale computational pathology and custom AI workflows. Review their platform on Proscia.

If you share whether you need this for clinical diagnostic use or research/pharma R&D , and which specific cancer type you are focusing on, I can help narrow down the best platform fit.

Yes. There are several AI-powered digital pathology platforms that can detect or quantify cancer cells from whole-slide images (WSIs). The best choice depends heavily on whether you need clinical diagnosis, research, or custom AI model development.

Strong options to consider

Paige is particularly interesting if your goal is clinical cancer detection. Its Prostate Suite, for example, analyzes H&E-stained prostate biopsy WSIs and includes an FDA-approved application that assists with primary diagnosis of prostate cancer. Its Breast Suite supports identification and classification of breast cancer.

HALO AI is probably the more flexible choice if you are doing research and want to detect individual cancer cells yourself. It has pre-trained applications for breast, colorectal, NSCLC, gastric, ovarian, and head-and-neck cancers, including H&E cancer-cell phenotyping. It also lets you train your own AI classifier without programming.

PathAI is worth considering if you need an enterprise/cloud pathology platform. Its PathExplore system performs AI-based segmentation, detection, and classification of millions of cells across H&E whole-slide images at single-cell resolution.

The key question

If you tell me:

1. Cancer type — e.g. breast, prostate, colon, lung, melanoma, etc.
2. Image type — H&E, IHC, immunofluorescence, etc.
3. Whether this is for clinical diagnosis or research
4. Whether you already have whole-slide images and which scanner produced them

…I can narrow this down to 2–3 suitable software packages, including their AI capabilities, regulatory status, approximate pricing/licensing approach, and whether they can detect individual cancer cells versus tumor regions.

Finding the right AI-powered pathology software depends on whether you need a solution for clinical diagnostics (FDA/CE-IVD cleared) or research use. Here are the leading platforms currently transforming digital pathology with AI cancer detection:

• Paige AI : Known for Paige Prostate and Paige Breast , which were among the first FDA-cleared AI products for primary digital pathology diagnosis. It excels at highlighting suspicious foci for prostate and breast cancer biopsies.
• PathAI : Offers AI-powered tools like PathExplore and various assay-specific algorithms focused on quantifying biomarker expression and detecting residual tumor cells, heavily used in both clinical research and bipharma partnerships.
• Aiforia : Provides a cloud-based platform (Aiforia Create and Clinical ) that allows users to train their own custom AI models for specific cancer types or tissue features, or use pre-trained models for breast, colon, and other cancers.
• Indica Labs : Their HALO AI module is a powerhouse for research environments, utilizing deep learning networks to classify and segment tumor microenvironments, immune cells, and cancer tissues across whole slide images.
• Ibex Medical Analytics : Specializes in Galen , an AI platform deployed in routine pathology labs to detect cancer and a wide range of other pathologies in prostate, breast, and gastric biopsies.
• Owkin : Focuses heavily on AI and machine learning for translational research and clinical trials, utilizing multimodal data to predict cancer outcomes and therapeutic responses.

To help narrow down the best option, could you let me know:

• Is this for clinical diagnostic use or academic/biotech research?
• Which specific cancer types or tissue stains (e.g., H&E, IHC) are you focusing on?

If you are looking for AI-powered pathology image analysis software that can detect cancer cells, the right choice depends on whether you need it for clinical diagnosis, research, clinical trials, or education. Here are several established options:

OptraSCAN also provides an integrated digital pathology platform combining whole-slide imaging with AI-powered diagnostic analysis for cancer detection, grading, and biomarker discovery.

What to look for when choosing one

• Regulatory status: If the goal is patient diagnosis, look for FDA-cleared/authorized or CE-marked clinical tools.
• Cancer type: Many AI models are specialized (e.g., prostate, breast, lung, colorectal, melanoma) rather than universal cancer detectors.
• Slide compatibility: Check support for your scanner format (whole-slide images such as SVS, NDPI, TIFF, etc.).
• Workflow integration: Hospital labs usually need integration with a LIS, PACS, or digital pathology viewer.
• Explainability: Heatmaps showing suspicious regions and cell-level annotations are useful for pathologist review.
• Deployment model: Cloud-based, on-premise, or hybrid options may matter for patient data governance.

If you tell me:

1. cancer type (breast, prostate, lung, colon, etc.),
2. clinical diagnosis vs research, and
3. whether you need free/open-source or commercial FDA-cleared software,

I can narrow this to the best-fit tools.